About Refeyn
Refeyn is a company based in Oxford (United Kingdom) founded in 2018 by Philipp Kukura. Refeyn has raised $32.92 million across 5 funding rounds from investors including University of Oxford, Oxford Technology and Northpond Ventures. Refeyn offers products and services including TwoMP, SamuxMP, KariTroMP, and MassFluidix HC System. Refeyn operates in a competitive market with competitors including 908 Devices, Advion, Impedimed, Zeteo Tech and Rigaku, among others.
- Headquarter Oxford, United Kingdom
- Founders Philipp Kukura
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Refeyn Ltd
- Date of Incorporation 27 Apr, 2018
- Jurisdiction OXFORD, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$32.92 M (USD)
in 5 rounds
-
Latest Funding Round
Not available
-
Investors
University of Oxford
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Refeyn
Refeyn offers a comprehensive portfolio of products and services, including TwoMP, SamuxMP, KariTroMP, and MassFluidix HC System.
Measures molecular mass of biomolecules with speed and accuracy.
Analyzes AAV vectors for development and manufacturing processes.
Characterizes viral particles for size, purity, and stability.
Supports mass photometry for enhanced sample handling.
People of Refeyn
Unlock access to complete
Software Development Team
12 people
Product Management Team
7 people
Sales and Marketing
6 people
Leadership Team
5 people
Operations Team
2 people
Finance and Accounting
2 people
Human Resources and Administration
2 people
Logistics Team
2 people
Unlock access to complete
Funding Insights of Refeyn
Refeyn has successfully raised a total of $32.92M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Refeyn
Refeyn has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Oxford, Oxford Technology and Northpond Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life sciences & tech sectors
|
Locked | Locked | Locked | |
|
Investment management services for science ventures are provided in Oxford.
|
Locked | Locked | Locked | |
|
Horizons Ventures is focused on investing in deep science and technology.
|
Locked | Locked | Locked |
Investor details for Refeyn
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Refeyn
Investment portfolio details for Refeyn
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Refeyn
Detailed financials for Refeyn
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Refeyn Comparisons
Peer comparison for Refeyn
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Refeyn
Refeyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 908 Devices, Advion, Impedimed, Zeteo Tech and Rigaku, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Handheld chemical detection devices are manufactured using mass spectrometry.
|
|
| Locked | Locked | Locked |
Microfluidics and mass spectrometry products are provided for clinical research.
|
|
| Locked | Locked | Locked |
Technologies for non-invasive fluid status assessment and monitoring are developed.
|
|
| Locked | Locked | Locked |
Biological mass spectrometers are manufactured for airborne microbe detection.
|
|
| Locked | Locked | Locked |
XRD, XRF, SAXS, Raman, metrology, and crystallography solutions are provided.
|
Detailed competitors of Refeyn
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Refeyn
Complete news archive for Refeyn
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Refeyn
Refeyn was founded in 2018.
Refeyn is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Refeyn is a funded company, having raised a total of $32.92M across 5 funding rounds to date.
Refeyn was founded in 2018 in Oxford, United Kingdom, within the biotechnology sector. Technology for assessing single molecular mass is created by the company, focusing on biomolecular analysis. Operations center on the development of mass photometry tools, with the Refeyn product utilizing single-molecule light scattering to identify properties such as size and concentration of biomolecules in solution.
Refeyn's top competitors include 908 Devices, Impedimed and Advion.
Refeyn offers TwoMP, SamuxMP, KariTroMP, and MassFluidix HC System.
Refeyn has 7 investors. Key investors include University of Oxford, Oxford Technology, Northpond Ventures, Oxford Science Enterprises, and Foresight Group.
The valuation of Refeyn is $71.2M as of Nov 2020.